HUM
HUMANA INC
NYSE · Healthcare · Medical - Healthcare Plans · US
$386.00
+0.38%Next report
Analyst consensus
- Next report date
- Nov 6, 2026
- EPS estimate
- -$1.04
- Revenue estimate
- $40.9B
Latest reported
- Last report date
- Jul 29, 2026
- EPS actual
- $7.61
- EPS estimate
- $7.27
- Revenue actual
- $40.9B
- Revenue estimate
- $40.6B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 11
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +5.0%
- Revenue beats (12Q)
- 7
Analyst ratings
Sell-side consensus
- Consensus
- Hold
- Price target
- $409
- PT range
- $300 – $502
- Analysts
- 14
4 Buy10 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jul 29, 2026 | $7.27 | $7.61 | Beat 4.68% | $40.9B |
| Apr 29, 2026 | $9.97 | $10 | Beat 3.41% | $39.6B |
| Feb 11, 2026 | -$4.01 | -$3.96 | Beat 1.25% | $32.5B |
| Nov 5, 2025 | $2.93 | $3.24 | Beat 10.58% | $32.6B |
| Jul 30, 2025 | $5.92 | $6.27 | Beat 5.91% | $32.4B |
| Apr 30, 2025 | $10 | $12 | Beat 15.00% | $32.1B |
| Oct 30, 2024 | $3.40 | $4.16 | Beat 22.35% | $29.4B |
| Jul 31, 2024 | $5.85 | $6.96 | Beat 18.97% | $29.5B |
| Jan 25, 2024 | -$0.07 | -$0.11 | Miss -57.14% | $26.5B |
| Nov 1, 2023 | $7.16 | $7.78 | Beat 8.66% | $26.4B |
| Aug 2, 2023 | $8.82 | $8.94 | Beat 1.36% | $26.7B |
| Feb 1, 2023 | $1.46 | $1.62 | Beat 10.96% | $22.4B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 6, 2026